FDA Approves Zytiga (abiraterone acetate) for Late-Stage Prostate Cancer
The long awaited FDA approval of Zytiga (abiraterone acetate), a once-daily oral agent, for the treatment of castration-resistant, metastatic prostate cancer following docetaxel chemotherapy has happened! Malecare celebrates this approval as it celebrates the significant [...]
Should Men on ADT Take Calcium and Vitamin D Supplementation?
As usual with prostate cancer there is no general agreement about whether or not men who are on a hormone blockade (ADT) to treat prostate cancer should be taking calcium and vitamin D supplements, however [...]
Minorities, Especially Blacks Are More Willing to Spend All for Cancer Care
An AP medical writer, Mike Stobb, wrote an interesting and unusual article about a survey that was conducted asking if people would be willing to spend everything they have on aggressive treatments that might prolong [...]
Statins & Prostate Cancer – Use Caution
There have been a number of recent studies that show that statins, (cholesterol lowering medications like Lipitor) can also lower PSA and even stop the progression of localized prostate cancer from progressing. I have not [...]
Provenge – The Final Step for Universal Medicaid & Medicare Coverage – Help Us
The battle to make sure that Provenge is available nationally (in the United States) to all men who meet the FDA approval requirements is continuing. We have made great steps through the “noise” that the [...]
Tasquinimod (TASQ)- A New Phase 3 Trial Shows Promise To Slow Disease Progression
Results from a recent international randomized phase II trial for the drug tasquinimod (TASQ), shows that TASQ is a potential therapy for men with advanced prostate cancer. The men who received TASQ on average went [...]